• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为肝肾联合移植受者转诊和治疗提供新的适应证。

Novel indications for referral and care for simultaneous liver kidney transplant recipients.

机构信息

Department of Medicine, University of California Los Angeles, Los Angeles, California.

Department of Medicine, Centura Health, Denver, Colorado.

出版信息

Curr Opin Nephrol Hypertens. 2024 May 1;33(3):354-360. doi: 10.1097/MNH.0000000000000970. Epub 2024 Feb 12.

DOI:10.1097/MNH.0000000000000970
PMID:38345405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10990015/
Abstract

PURPOSE OF REVIEW

Kidney dysfunction is challenging in liver transplant candidates to determine whether it is reversible or not. This review focuses on the pertinent data on how to best approach liver transplant candidates with kidney dysfunction in the current era after implementing the simultaneous liver kidney (SLK) allocation policy and safety net.

RECENT FINDINGS

The implementation of the SLK policy inverted the steady rise in SLK transplants and improved the utilization of high-quality kidneys. Access to kidney transplantation following liver transplant alone (LTA) increased with favorable outcomes. Estimating GFR in liver transplant candidates remains challenging, and innovative methods are needed. SLK provided superior patient and graft survival compared to LTA only for patients with advanced CKD and dialysis at least 3 months. SLK can provide immunological protection against kidney rejection in highly sensitized candidates. Post-SLK transplant care is complex, with an increased risk of complications and hospitalization.

SUMMARY

The SLK policy improved kidney access and utilization. Transplant centers are encouraged, under the safety net, to reserve SLK for liver transplant candidates with advanced CKD or dialysis at least 3 months while allowing lower thresholds for highly sensitized patients. Herein, we propose a practical approach to liver transplant candidates with kidney dysfunction.

摘要

目的综述

在确定肝移植候选者的肾功能是否可逆时,肾功能障碍具有挑战性。本综述重点介绍了在实施肝肾联合(SLK)分配政策和安全网后,如何在当前时代最好地处理伴有肾功能障碍的肝移植候选者的相关数据。

最新发现

SLK 政策的实施扭转了 SLK 移植稳步上升的趋势,并提高了高质量肾脏的利用率。与单独肝移植(LTA)相比,接受肾移植的机会增加,且结果良好。在肝移植候选者中估算肾小球滤过率仍然具有挑战性,需要创新方法。对于至少接受 3 个月透析的晚期 CKD 患者,SLK 与仅 LTA 相比,为患者和移植物提供了更好的生存优势。SLK 可为高度致敏候选者提供针对肾脏排斥的免疫保护。SLK 后移植护理复杂,并发症和住院风险增加。

总结

SLK 政策改善了肾脏的可及性和利用率。在安全网下,鼓励移植中心为至少接受 3 个月透析的晚期 CKD 或透析的肝移植候选者保留 SLK,同时为高度致敏患者放宽阈值。在此,我们提出了一种针对伴有肾功能障碍的肝移植候选者的实用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423e/10990015/dd1da997f8b7/conhy-33-354-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423e/10990015/f77483d2f47d/conhy-33-354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423e/10990015/a248d4058ffc/conhy-33-354-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423e/10990015/dd1da997f8b7/conhy-33-354-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423e/10990015/f77483d2f47d/conhy-33-354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423e/10990015/a248d4058ffc/conhy-33-354-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/423e/10990015/dd1da997f8b7/conhy-33-354-g003.jpg

相似文献

1
Novel indications for referral and care for simultaneous liver kidney transplant recipients.为肝肾联合移植受者转诊和治疗提供新的适应证。
Curr Opin Nephrol Hypertens. 2024 May 1;33(3):354-360. doi: 10.1097/MNH.0000000000000970. Epub 2024 Feb 12.
2
Effect of pre-end-stage kidney disease nephrology care on the association between neighborhood poverty and referral for kidney transplantation among patients with end-stage kidney disease.终末期肾病前期肾病护理对社区贫困与终末期肾病患者肾移植转诊之间关联的影响。
J Clin Epidemiol. 2025 Jun 24;185:111878. doi: 10.1016/j.jclinepi.2025.111878.
3
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
4
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.用于治疗肾移植受者中已存在的和新发糖尿病的降糖药物。
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2.
5
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.用于肾移植受者诱导治疗的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2.
6
Belatacept for kidney transplant recipients.用于肾移植受者的贝拉西普。
Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD010699. doi: 10.1002/14651858.CD010699.pub2.
7
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
8
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.用于治疗肾移植受者急性排斥反应的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4.
9
Defining the Etiology of Renal Allograft Dysfunction Using Banff 2019 Classification: Correlation with Post-Transplant Duration and Creatinine Levels-A Comprehensive Analysis of 200 Renal Biopsies at a Tertiary Care Medical Center Hospital.使用2019年班夫分类法定义肾移植功能障碍的病因:与移植后持续时间和肌酐水平的相关性——对一家三级医疗中心医院200例肾活检的综合分析
Int J Surg Pathol. 2024 Oct 3:10668969241283737. doi: 10.1177/10668969241283737.
10
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.接受透析治疗并等待已故捐赠者肾脏移植的成年人的经历:一项系统综述。
JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973.

本文引用的文献

1
One size does not fit all: Differential benefits of simultaneous liver-kidney transplantation by eligibility criteria.一刀切并不适用所有人:按资格标准来看,肝肾联合移植的获益存在差异。
Liver Transpl. 2023 Nov 1;29(11):1208-1215. doi: 10.1097/LVT.0000000000000191. Epub 2023 Jun 19.
2
Predictors of Length of Stay and Mortality During Simultaneous Liver-Kidney Transplant Index Admission: Results From the US-Multicenter SLKT Consortium.肝肾联合移植首次住院期间住院时长和死亡率的预测因素:来自美国多中心肝肾联合移植协会的结果
Transplant Direct. 2022 Nov 11;8(12):e1408. doi: 10.1097/TXD.0000000000001408. eCollection 2022 Dec.
3
Burden of early hospitalization after simultaneous liver-kidney transplantation: Results from the US Multicenter SLKT Consortium.
肝-肾联合移植后早期住院负担:来自美国多中心 SLKT 联盟的结果。
Liver Transpl. 2022 Nov;28(11):1756-1765. doi: 10.1002/lt.26523. Epub 2022 Jul 4.
4
Kidney utilization and outcomes of liver transplant recipients who were listed for kidney after liver transplant after the implementation of safety net policy.实施安全网政策后,肝移植受者在肝移植后被列入肾移植名单的肾脏利用情况及结局。
Clin Transplant. 2022 Feb;36(2):e14522. doi: 10.1111/ctr.14522. Epub 2021 Nov 9.
5
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.MELD 3.0:适应新时代的终末期肝病模型。
Gastroenterology. 2021 Dec;161(6):1887-1895.e4. doi: 10.1053/j.gastro.2021.08.050. Epub 2021 Sep 3.
6
Accounting for Age in the Definition of Chronic Kidney Disease.在慢性肾脏病的定义中考虑年龄因素。
JAMA Intern Med. 2021 Oct 1;181(10):1359-1366. doi: 10.1001/jamainternmed.2021.4813.
7
Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: A 2-year review of the OPTN's allocation policy.制定肝肾联合移植医学准入标准的同时提供安全网:OPTN 分配政策的两年回顾。
Am J Transplant. 2021 Nov;21(11):3593-3607. doi: 10.1111/ajt.16761. Epub 2021 Aug 4.
8
Estimating Glomerular Filtration Rate in Cirrhosis Using Creatinine-Based and Cystatin C-Based Equations: Systematic Review and Meta-Analysis.使用基于肌酐和胱抑素 C 的方程估算肝硬化患者的肾小球滤过率:系统评价和荟萃分析。
Liver Transpl. 2021 Nov;27(11):1538-1552. doi: 10.1002/lt.26216. Epub 2021 Aug 1.
9
Paradigm Change in Liver Transplantation Practice After the Implementation of the Liver-Kidney Allocation Policy.肝肾联合分配政策实施后肝移植实践的范式转变
Liver Transpl. 2021 Nov;27(11):1563-1576. doi: 10.1002/lt.26107. Epub 2021 Aug 16.
10
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.腹水、自发性细菌性腹膜炎和肝肾综合征的诊断、评估及管理:美国肝病研究协会2021年实践指南
Hepatology. 2021 Aug;74(2):1014-1048. doi: 10.1002/hep.31884.